Clinical Trial Update: Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial to evaluate the safety and efficacy of NDV01 KIT for high-grade non-muscle-invasive bladder cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• NDV01 KIT

Snippet

Sponsor: Relmada Therapeutics, Inc. | Conditions: Non Muscle Invasive Bladder Cancer | Phase 2 | Status: RECRUITING